Treatment of Hypoglycemia in NPO Hospitalized Patients
For hospitalized patients who are NPO (nothing by mouth) and develop hypoglycemia, administer intravenous dextrose in 5-10 gram aliquots, repeating every minute until symptoms resolve or blood glucose exceeds 70 mg/dL, with a maximum total dose of 25 grams. 1
Immediate Management Algorithm
Step 1: Confirm Hypoglycemia and Stop Insulin
- Check blood glucose immediately before initiating treatment 1
- Stop any insulin infusion immediately to prevent recurrence 1
- Document the hypoglycemic episode in the medical record 2
Step 2: Administer IV Dextrose (NPO Patients)
Since the patient cannot take oral glucose:
- Administer intravenous dextrose in 5-10 gram aliquots 1
- Repeat every minute until symptoms resolve or blood glucose exceeds 70 mg/dL 1
- Maximum total dose is 25 grams 1
- Alternative: Intramuscular glucagon (1 mg for adults >25 kg; 0.5 mg for patients <25 kg) if IV access is unavailable 3
Step 3: Monitor Response
- Recheck blood glucose at 15 minutes post-treatment 1
- Continue monitoring every 1-2 hours if patient remains on insulin therapy 1
- If blood glucose remains <70 mg/dL after 15 minutes, repeat treatment 1
Step 4: Prevent Recurrence
- Once symptoms resolve and glucose normalizes, provide starchy or protein-rich foods if more than 1 hour until next meal (once patient is no longer NPO) 1
- Any severe hypoglycemic episode requiring external assistance mandates reevaluation of the diabetes management plan 1
Insulin Management for NPO Patients
The preferred insulin regimen for NPO patients is basal insulin plus correction doses only—NOT sliding scale insulin alone. 2
Recommended Approach:
- Basal plus correction insulin regimen is the preferred treatment for patients with poor oral intake or who are NPO 2
- Sliding scale insulin (SSI) as the sole method is strongly discouraged 2
- Adjust basal insulin doses downward when patient becomes NPO to prevent hypoglycemia 2
Common Triggering Events to Address
Investigate and correct these preventable causes 2:
- Inappropriate timing of insulin in relation to meals or NPO status 2
- Failure to reduce insulin doses when patient becomes NPO 2
- Unexpected interruption of enteral feedings or parenteral nutrition 2
- Reduced infusion rate of intravenous dextrose 2
- Sudden reduction of corticosteroid dose 2
Critical Pitfalls to Avoid
- Never administer oral glucose to NPO patients or those with altered mental status—use IV dextrose or IM glucagon instead 1
- Do not continue insulin infusions during hypoglycemia treatment 1
- Do not rely on sliding scale insulin alone for NPO patients—this reactive approach leads to both hyper- and hypoglycemia 2
- Do not use 5% dextrose solutions in acute stroke patients, as they can worsen cerebral edema 1
Special Considerations
For Neurologic Injury Patients:
- Treat blood glucose <100 mg/dL rather than the standard <70 mg/dL threshold 1
Post-Treatment:
- Patients with diabetes may require insulin supplementation after treatment to prevent rebound hyperglycemia 1
- Review the patient's treatment regimen any time blood glucose <70 mg/dL occurs 2